Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Afatinib
Afatinib
850140-72-6
|
485.163
|
4.49
Afatinib is an antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. It is a 4-anilinoquinazoline tyrosine kinase inhibitor.
BIBW2992 | Gilotrif | Tovok | afatanib | afatinib | gilotrif | giotrif
Afatinib is an antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. It is a 4-anilinoquinazoline tyrosine kinase inhibitor.
BIBW2992 | Gilotrif | Tovok | afatanib | afatinib | gilotrif | giotrif
$42/5 mg
(EBC)
1
We provide 0 compound for Afatinib